TARO News and Press, Taro Pharmaceutical Industries Ltd. From 07/19/23

Krensavage Asset Management Opposes Sun's Lowball Bid for Taro PR Newswire NEW YORK , July 19, 2023 /PRNewswire/ -- As the largest minority shareholder 1 of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC opposes Sun Pharmace...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2023, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor Relations section of Taro&#...

2023-06-02 14:41:08 ET Summary Taro received a $38/share offer from Sun Pharma last month. The deal represents a decent premium to the firm's market value at the time and a 12% premium to my estimate of fair value. Further insights reveal the deal could be valuable to Taro sha...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is one of today's top gainers. The company's shares are currently up 23.11% on the day to $36.18. Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter ...

2023-05-30 13:14:47 ET Gainers: Atento ( ATTO ) +92% . Wearable Devices ( WLDS ) +86% . T2 Biosystems ( TTOO ) +55% . Arlington Asset Investment ( AAIC ) +45% . Equitrans Midstream Corporation ( ETRN ) +36% . The Glimpse Grou...

2023-05-30 12:25:31 ET Shares of Taro Pharmaceutical Industries (NYSE: TARO) were up more than 23% Tuesday morning after the company reported late Friday that in a Securities and Exchange Commission (SEC) filing, it was looking at a buyout offer from Sun Pharmaceuticals, India's lar...

2023-05-30 10:01:01 ET Gainers: HeartBeam ( BEAT ) +23% . Taro Pharmaceutical Industries ( TARO ) +22% . Akebia Therapeutics ( AKBA ) +19% . Corvus Pharmaceuticals ( CRVS ) +16% . Immix Biopharma ( IMMX ) +13% . Losers:...

2023-05-24 03:47:46 ET Taro Pharmaceutical press release ( NYSE: TARO ): Q1 GAAP EPS of $0.18 misses by $0.05 . Revenue of $146.6M misses by $4.09M . Gross profit of $75.7 million (51.6% of net sales) compared to $77.3 million (54.0% of net sales). Research...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2023. Quarter ended March 31, 2023* Highlights ─ compared to March 31, 2022 Net sales of ...

2023-05-22 17:35:17 ET Major earnings expected after the bell on Tuesday include: Agilent Technologies ( A ) Intuit ( INTU ) Palo Alto Networks ( PANW ) Toll Brothers ( TOL ) V.F. Corp. ( VFC ) For further details see: Notable earnings aft...